Shanghai Pharmaceuticals Holding Co., Ltd (SHA:601607)
China · Delayed Price · Currency is CNY 16.13
+0.06 (0.37%)
Jul 10, 2026, 3:00 PM CST
SHA:601607 Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, SHA:601607 stock has a consensus rating of "Buy" and an average price target of ¥20.65. The average 1-year stock price forecast is 28.02% higher than the current stock price, while the lowest is ¥12.50 (-22.50%) and the highest is ¥25.88 (+60.45%).
Price Target: ¥20.65 (+28.02%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SHA:601607 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 4 | 4 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 9 | 9 | 10 | 10 | 10 |
Financial Forecast
Revenue This Year
297.27B
from 283.58B
Increased by 4.83%
Revenue Next Year
317.39B
from 297.27B
Increased by 6.77%
EPS This Year
1.37
from 0.80
Increased by 70.67%
EPS Next Year
1.60
from 1.37
Increased by 17.48%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 302.1B | ||
| Avg | 297.3B | ||
| Low | 292.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 6.5% | ||
| Avg | 4.8% | ||
| Low | 3.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.37 | ||
| Avg | 1.37 | ||
| Low | 1.37 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 70.7% | ||
| Avg | 70.7% | ||
| Low | 70.7% |